Clovis Oncology, Inc.·4

Dec 31, 11:37 AM ET

McKinley Edward J 4

4 · Clovis Oncology, Inc. · Filed Dec 31, 2012

Insider Transaction Report

Form 4
Period: 2012-12-27
Transactions
  • Exercise/Conversion

    Common Stock

    2012-12-27$3.08/sh+6,896$21,240328,189 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2012-12-276,8960 total
    Exercise: $3.08Exp: 2020-12-02Common Stock (6,896 underlying)
  • Exercise/Conversion

    Common Stock

    2012-12-27$0.29/sh+25,862$7,500321,293 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2012-12-2725,8620 total
    Exercise: $0.29Exp: 2019-08-26Common Stock (25,862 underlying)
Footnotes (2)
  • [F1]The option was immediately exercisable as to both vested and unvested shares. 25% of the shares subject to the option vested on each of August 26, 2009, August 26, 2010, August 26, 2011 and August 26, 2012.
  • [F2]The option was immediately exercisable as to both vested and unvested shares. 25% of the shares subject to the option vested on each of December 2, 2010, August 26, 2011 and August 26, 2012, and 25% of the shares subject to the option shall vest on August 26, 2013. To the extent the reporting person exercised the option as to unvested shares, the reporting person received restricted shares that will vest in accordance with the vesting schedule for the option.

Documents

1 file
  • 4
    rrd365134.xmlPrimary

    FORM 4